Kansas Patients Now Have Access To Medicinal Cannabis Without A State Law

On June 2, Governor Laura Kelly (D) signed new legislation that would allow Kansans to obtain prescription drugs derived from cannabis-related products.

Although medical marijuana is not yet legalized in the state, the bill will allow residents to obtain cannabis-derived medications, as long as they are approved by the Food and Drug Administration (FDA), reported cjonline.com.

What Are These Cannabis Medications?

In 2018, the FDA approved a drug derived from cannabis that is used to treat epilepsy caused by two rare conditions, Lennox- Gastaut syndrome and Dravet syndrome. The drug is called Epidiolex.

The FDA has also approved three products related to synthetic cannabis, which are used to treat nausea in AIDS patients and those undergoing chemotherapy during cancer treatment.

"There are a number of products currently in clinical trials anticipated to be submitted for FDA approval in the coming months and years," Alexandra Blasi, executive secretary of the Kansas Board of Pharmacy said in a statement. "Now Kansas will be among the first to allow these drugs to be lawfully prescribed in our state if and when the FDA deems them safe and effective.”

Senator Rob Olson (R), chairman of the Senate Committee on State and Federal Affairs, said in a statement that he regretted and took responsibility that the policy had not passed his chamber.

In May, Senate president Ty Masterson (R) told reporters that he wasn't sure any of the proposals to date were able to garner the majority of votes needed to pass his chamber. "I think the subject is ripe and you'll see it next year," Masterson said.

Efforts To Legalize Medical Marijuana In Kansas Stalls

In 2022, the Kansas House appointed key lawmakers from both chambers to a conference committee that would design the details for a medical marijuana legalization bill. Cannabis advocates called the move a clear sign that reform is inevitable and can be expected soon. However, it seems that Senate Bill 12, won't gain traction.

"Given we plan to only be there one day, it's unlikely that work could be completed on that item," Mike Pirner, a spokesman for senate leadership said in May.

Photo By Megan Burns On Unsplash

Posted In: EpidiolexKansas Board Of PharmacyLaura KellyRob OlsonTy MastersonU.S. Food and Drug AdministrationCannabisGovernmentRegulationsPoliticsMarketsGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.